The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Preclinical efficacy of new investigational drug ONC201 and analogs ONC212 and ONC206 against patient-derived pancreatic cancer cell lines.

Avital  Lev

No Relationships to Disclose

Jessica  Wagner

No Relationships to Disclose

Amriti R.  Lulla

No Relationships to Disclose

David T.  Dicker

No Relationships to Disclose

Wafik S.  El-Deiry

Stock and Other Ownership Interests  - Oncoceutics; p53-Therapeutics

Consulting or Advisory Role - Morphotek

Patents, Royalties, Other Intellectual Property - I hold patents and have submitted patents relevant to my academic laboratory research. However, these patent have no relationship with my GI ASCO presentation.